meclizine hydrochloride tablets, usp 12.5 mg

meclizine hydrochloride tablets, usp 12.5 mg
SPL v3
SPL
SPL Set ID acdf636c-66f1-4a1f-87a8-786f51d75708
Route
oral
Published
Effective Date 2024-11-13
Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
meclizine (12.5 mg)
Inactive Ingredients
silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose

Identifiers & Packaging

Pill Appearance
Imprint: AB;12 Shape: round Color: white Size: 7 mm Score: 1
Marketing Status
otc monograph drug active Since 2024-07-22

Purpose

Antiemetic

Description

Meclizine HCl, USP 12.5 mg


Medication Information

Warnings and Precautions

Do not take this product, unless directed by a doctor, if you have

  • glaucoma
  • a breathing problem such as emphysema or chronic bronchitis
  • trouble urinating due to an enlarged prostate gland
Warnings

Do not use in children under 12 years of age unless directed by a doctor.

Uses

prevents and treats nausea, vomiting or dizziness associated with motion sickness.

Purpose

Antiemetic

Directions

dosage should be taken one hour before travel starts

adults and children 12 years and over take 2 or 4 tablets once daily or as directed by a doctor

Other Information
  • store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].
Inactive Ingredients

colloidal silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate, microcrystalline cellulose

Description

Meclizine HCl, USP 12.5 mg

Section 42229-5

Manufactured by:

Unique Pharmaceutical Laboratories

(A Div. of J.B.Chemicals &

Pharmaceuticals Ltd.),

Mumbai 400 030, India

Mfg. Lic. No.: G/1430

Distributed by:

Rising Pharma Holdings, Inc.

East Brunswick, NJ 08816

Issued: 02/2024

138528

Section 50565-1

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Section 53414-9

If pregnant or breast-feeding, ask a health professional before use.

Drug Facts

Meclizine HCl, USP 12.5 mg

Questions Or Comments?

Call 1-844-474-7464 Monday to Friday 8 AM - 5 PM ET

When Using This Product
  • do not exceed recommended dosage
  • may cause drowsiness
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • avoid alcoholic drinks
  • use caution when driving a motor vehicle or operating machinery
Principal Display Panel 12.5 Mg Tablets Container Label

NDC 57237-333-01

Meclizine Hydrochloride Tablets, USP



12.5 mg

100 Tablets


Structured Label Content

Warnings and Precautions (34071-1)

Do not take this product, unless directed by a doctor, if you have

  • glaucoma
  • a breathing problem such as emphysema or chronic bronchitis
  • trouble urinating due to an enlarged prostate gland
Warnings

Do not use in children under 12 years of age unless directed by a doctor.

Uses

prevents and treats nausea, vomiting or dizziness associated with motion sickness.

Purpose

Antiemetic

Directions

dosage should be taken one hour before travel starts

adults and children 12 years and over take 2 or 4 tablets once daily or as directed by a doctor

Other Information (Other information)
  • store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].
Inactive Ingredients (Inactive ingredients)

colloidal silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate, microcrystalline cellulose

Section 42229-5 (42229-5)

Manufactured by:

Unique Pharmaceutical Laboratories

(A Div. of J.B.Chemicals &

Pharmaceuticals Ltd.),

Mumbai 400 030, India

Mfg. Lic. No.: G/1430

Distributed by:

Rising Pharma Holdings, Inc.

East Brunswick, NJ 08816

Issued: 02/2024

138528

Section 50565-1 (50565-1)

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Section 53414-9 (53414-9)

If pregnant or breast-feeding, ask a health professional before use.

Drug Facts

Meclizine HCl, USP 12.5 mg

Questions Or Comments? (Questions or comments?)

Call 1-844-474-7464 Monday to Friday 8 AM - 5 PM ET

When Using This Product (When using this product)
  • do not exceed recommended dosage
  • may cause drowsiness
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • avoid alcoholic drinks
  • use caution when driving a motor vehicle or operating machinery
Principal Display Panel 12.5 Mg Tablets Container Label (PRINCIPAL DISPLAY PANEL - 12.5 mg tablets container label)

NDC 57237-333-01

Meclizine Hydrochloride Tablets, USP



12.5 mg

100 Tablets


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)